Á¦34Â÷ ´ëÇѳúÁ¾¾çÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-14
±³À°ÀÏÀÚ : 2024-06-14
±³À°Àå¼Ò : È£ÅÚ ¿À³ë¸¶ ´ëÀü, 5Ãþ ±×·£µåº¼·ë
±³À°ÁÖÁ¦ : Á¦34Â÷ ´ëÇѳúÁ¾¾çÇÐȸ Á¤±âÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѳúÁ¾¾çÇÐȸ
´ã´çÀÚ : ±è¹Ì°æ
¿¬¶ôó : 02-523-6811
À̸ÞÀÏ : koreabraintumor@gmail.com
±³À°Á¾·ù : ½Å°æ¿Ü°ú
Âü¼®¿¹»óÀÎ : 70¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª : ´ëÀü±¤¿ª½Ã
±³À°½Ã°£ : 5 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í Àü¹®ÀÇ 5¸¸¿ø, Çлý 1¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06¿ù 14ÀÏ ±×·£µåº¼·ë 09:00~09:35 Effect of osteoporotic conditions on the development of peritumoral brain edema after LINAC-based radiation treatment in patients with intracranial meningioma ±èÀç¿ë(ºÐ´ç¼¿ï´ëº´¿ø)
±³À°½Ã°£ 06¿ù 14ÀÏ ±×·£µåº¼·ë 09:35~10:10 miR-542-3p Contributes to the HK2-Mediated High Glycolytic Phenotype in Human Glioma Cells °½ÅÇõ(°í·Á´ë¾È¾Ïº´¿ø)
±³À°½Ã°£ 06¿ù 14ÀÏ ±×·£µåº¼·ë 10:10~10:30 Laser-interstitial thermal therapy ¾È½ºµ¥¹Ý(°¡Å縯´ë ¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 06¿ù 14ÀÏ ±×·£µåº¼·ë 10:30~10:50 Photodynamic therapy Á¤±ÔÇÏ(¼º±Õ°ü´ë »ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 06¿ù 14ÀÏ ±×·£µåº¼·ë 10:50~11:10 Focused ultrasound - New techniques for brain tumor treatment À¯Áöȯ(°³²¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 06¿ù 14ÀÏ ±×·£µåº¼·ë 11:30~11:50 Advances in biomedical imaging technologies for understanding and diagnosing brain disorders ±¸ÅÂÀ±(Çѱ¹°úÇбâ¼ú¿ø(KAIST))
±³À°½Ã°£ 06¿ù 14ÀÏ ±×·£µåº¼·ë 11:50~12:30 The anatomy of the human cognitive and emotional system and how it affects neurosurgery Michael Sughrue(Omniscent Neurotechnologies)
±³À°½Ã°£ 06¿ù 14ÀÏ ±×·£µåº¼·ë 14:10~14:50 Pretreatment case presentations - To cut or not to cut, that is the question! ³ª¹Î±Õ(ÇѾç´ëÇб³¼¿ïº´¿ø)
±³À°½Ã°£ 06¿ù 14ÀÏ ±×·£µåº¼·ë 14:50~15:30 Posttreatment results - To cut or not to cut, that is the question! ¼¿µ¹ü(¿µ³²´ëÇб³º´¿ø)
±³À°½Ã°£ 06¿ù 14ÀÏ ±×·£µåº¼·ë 15:50~16:25 Deep neural network based predictive model of peri-tumoral edema following Gamma Knife radiosurgery for meningioma Á¤½Å(Àü³²´ëÇб³º´¿ø)
±³À°½Ã°£ 06¿ù 14ÀÏ ±×·£µåº¼·ë 16:25~16:50 Validation of levetiracetam as a sensitizer of concurrent chemoradiation therapy in newly diagnosed glioblastoma: a multicenter, open-label phase 2 study ±èÁ¤ÈÆ(¼¿ï¾Æ»êº´¿ø)